Get started
Author

Shan-Ling Xu

Observed names: S. Xu, Shan-ling Xu, Shidong Xu
ORCID: 0009-0007-4650-8220
Observed ORCID: 0009-0007-4650-8220
OpenAlex ID: A5008879270
Intensive care unit outcomes and prognostic factors of colorectal cancer
2025 · Qian Dong, Rui Xia, et al. · World Journal of Gastrointestinal Oncology · 5
Effects of the microRNA-99a-5p/VLDLR axis in lung cancer cell sensitivity to chemotherapy and its mechanism
2023 · Yaoguo Lang, Xianglong Kong, et al. · Brazilian Journal of Pharmaceutical Sciences · 3
PDF
Intensive care unit outcomes and prognostic factors of esophageal cancer: A cross-sectional study in Chinese cancer-specialized hospitals
2025 · Jiang-Feng Tang, Rui Xia, et al. · World Journal of Gastrointestinal Oncology · 1
Metagenomic next-generation sequencing (mNGS) for detecting pathogens and antimicrobial resistance genes (ARGs), and guiding antimicrobial therapy in cancer patients from Southwest China
2026 · Qian Zhao, Qian Wan, et al. · Journal of Global Antimicrobial Resistance
521P Camrelizumab combined with chemotherapy and apatinib as first-line therapy for extensive-stage small cell lung cancer: A phase II, single-arm, exploratory research
2023 · Y. Zhao, J. Liu, et al. · Annals of Oncology
PDF
104P Camrelizumab combined with chemotherapy and apatinib as first-line therapy for extensive-stage small cell lung cancer: A phase II single-arm, exploratory research
2022 · Y. Zhao, X. Wang, et al. · Immuno-Oncology Technology
Works count: 6
Citation count: 9
H-index: 2
I10-index:
Year
Topic
Type